T. Rowe Price Associates
MXCT icon

T. Rowe Price Associates’s MaxCyte MXCT Stock Holding History

T. Rowe Price Associates’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37K Hold
51,537
– – ﹤0.01% 3086
2025
Q4 		$80K Hold
51,537
– – ﹤0.01% 2975
2025
Q3 		$82K Hold
51,537
– – ﹤0.01% 2958
2025
Q2 		$113K Buy
51,537
+6,388
+14% +$15.5K ﹤0.01% 2872
2025
Q1 		$124K Buy
45,149
+2,793
+7% +$11K ﹤0.01% 2779
2024
Q4 		$177K Buy
42,356
+8,951
+27% +$33.8K ﹤0.01% 2731
2024
Q3 		$130K Hold
33,405
– – ﹤0.01% 2769
2024
Q2 		$131K Buy
33,405
+8,206
+33% +$35.3K ﹤0.01% 2703
2024
Q1 		$106K Buy
25,199
+4,320
+21% +$20.3K ﹤0.01% 2771
2023
Q4 		$99K Buy
20,879
+2,082
+11% +$8.11K ﹤0.01% 2719
2023
Q3 		$59K Buy
18,797
+674
+4% +$2.71K ﹤0.01% 2756
2023
Q2 		$84K Buy
18,123
+1,494
+9% +$6.87K ﹤0.01% 2725
2023
Q1 		$83K Buy
16,629
+1,455
+10% +$7.17K ﹤0.01% 2717
2022
Q4 		$83K Buy
15,174
+1,681
+12% +$10.3K ﹤0.01% 2749
2022
Q3 		$88K Buy
+13,493
New +$75.3K ﹤0.01% 2753
2022
Q2 		– Sell
-37,018
Closed -$259K – 2996
2022
Q1 		$259K Sell
37,018
-519,798
-93% -$3.55M ﹤0.01% 2609
2021
Q4 		$5.67M Buy
556,816
+55,494
+11% +$596K ﹤0.01% 1480
2021
Q3 		$6.12M Buy
+501,322
New +$7.56M ﹤0.01% 1489

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

T. Rowe Price Associates's MXCT Position: Q1 2026 in Review

T. Rowe Price Associates held its MaxCyte (MXCT) position steady in Q1 2026 at 51,537 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #3086.

T. Rowe Price Associates first reported a position in MXCT in Q3 2021 and has held it in 18 quarters since. The position peaked at $6.12M in Q3 2021. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • T. Rowe Price Associates held 51,537 shares of MaxCyte worth $37K as of Q1 2026.
  • T. Rowe Price Associates left its MaxCyte share count unchanged in Q1 2026.
  • MaxCyte made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #3086 holding.
  • T. Rowe Price Associates first reported a position in MaxCyte in Q3 2021 and has held it in 18 quarters since.
  • T. Rowe Price Associates's MaxCyte position peaked at $6.12M in Q3 2021.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.